163 related articles for article (PubMed ID: 34010238)
21. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
22. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
[TBL] [Abstract][Full Text] [Related]
23. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
[TBL] [Abstract][Full Text] [Related]
24. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
BMJ; 2014 Jan; 348():g130. PubMed ID: 24435414
[TBL] [Abstract][Full Text] [Related]
25. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study.
Wikström I; Lindell M; Sanner K; Wilander E
Br J Cancer; 2011 Jul; 105(3):337-9. PubMed ID: 21730977
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening.
Stenvall H; Wikström I; Wilander E
Acta Derm Venereol; 2007; 87(3):243-5. PubMed ID: 17533491
[TBL] [Abstract][Full Text] [Related]
27. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
28. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
[TBL] [Abstract][Full Text] [Related]
29. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
30. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
[TBL] [Abstract][Full Text] [Related]
31. Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.
Lamin H; Eklund C; Elfström KM; Carlsten-Thor A; Hortlund M; Elfgren K; Törnberg S; Dillner J
BMJ Open; 2017 May; 7(5):e014788. PubMed ID: 28566363
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
Rebolj M; Bonde J; Preisler S; Ejegod D; Rygaard C; Lynge E
PLoS One; 2016; 11(1):e0147326. PubMed ID: 26789267
[TBL] [Abstract][Full Text] [Related]
33. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
[TBL] [Abstract][Full Text] [Related]
34. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
35. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
36. [Value of the BioPerfectus multiplex real time HPV assay for self-collected samples cervical cancer screening].
Chen Q; Du H; Wang C; Hu QC; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):307-311. PubMed ID: 31154711
[No Abstract] [Full Text] [Related]
37. Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age.
Ernstson A; Asciutto KC; Sturesson J; Norén J; Forslund O; Borgfeldt C
Anticancer Res; 2019 Jan; 39(1):381-386. PubMed ID: 30591484
[TBL] [Abstract][Full Text] [Related]
38. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
39. HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
Sultana F; Gertig DM; English DR; Simpson JA; Drennan KT; Wrede CD; Mullins RM; Heley S; Saville M; Brotherton JM
J Med Screen; 2022 Sep; 29(3):185-193. PubMed ID: 35313763
[TBL] [Abstract][Full Text] [Related]
40. Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.
Chatzistamatiou K; Chatzaki Ε; Constantinidis Τ; Nena E; Tsertanidou A; Agorastos T
J Obstet Gynaecol; 2017 Nov; 37(8):1059-1064. PubMed ID: 28631511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
